TY - JOUR
T1 - Does stigma leave its mark? The interplay between negative effects of perceived stigma with positive effect of self-esteem on long-term social functioning in schizophrenia
AU - Ali, Mariam P.
AU - Tiles-Sar, Natalia
AU - Simons, Claudia J.P.
AU - Osicka, Dominika A.
AU - Habtewold, Tesfa Dejenie
AU - Van der Meer, Lisette
AU - Bruggeman, Richard
AU - Alizadeh, Behrooz Z.
AU - Genetic Risk and Outcome of Psychosis (GROUP) Investigators
N1 - Funding Information:
The infrastructure for the GROUP study is funded through the Geestkracht programme of the Dutch Health Research Council (Zon-Mw, grant number 10-000-1001 ), and matching funds from participating pharmaceutical companies ( Lundbeck , AstraZeneca , Eli Lilly , Janssen Cilag ) and universities and mental health care organizations (Amsterdam: Academic Psychiatric Centre of the Academic Medical Center and the mental health institutions: GGZ Ingeest , Arkin , Dijk en Duin , GGZ Rivierduinen , Erasmus Medical Centre , GGZ Noord Holland Noord . Groningen: University Medical Center Groningen and the mental health institutions: Lentis , GGZ Friesland , GGZ Drenthe , Dimence , Mediant , GGNet Warnsveld , Yulius Dordrecht and Parnassia psycho-medical center The Hague . Maastricht: Maastricht University Medical Centre and the mental health institutions: GGzE , GGZ Breburg , GGZ Oost-Brabant , Vincent van Gogh voor Geestelijke Gezondheid , Mondriaan , Virenze riagg , Zuyderland GGZ , MET ggz , Universitair Centrum Sint-Jozef Kortenberg , CAPRI University of Antwerp , PC Ziekeren Sint-Truiden , PZ Sancta Maria Sint-Truiden , GGZ Overpelt , OPZ Rekem . Utrecht: University Medical Center Utrecht and the mental health institutions Altrecht , GGZ Centraal and Delta ).
Funding Information:
We are grateful to the patients, their families, and healthy subjects for their generosity of time and effort. Furthermore, we would like to thank all research personnel involved in the GROUP project, in particular: Joyce van Baaren, Erwin Veermans, Ger Driessen, Truda Driesen, and Erna van't Hag. Mariam Ali was supported by a master's scholarship from the Graduate School for Medical Science, University of Groningen , Groningen, The Netherlands.
Funding Information:
The infrastructure for the GROUP study is funded through the Geestkracht programme of the Dutch Health Research Council (Zon-Mw, grant number 10-000-1001), and matching funds from participating pharmaceutical companies (Lundbeck, AstraZeneca, Eli Lilly, Janssen Cilag) and universities and mental health care organizations (Amsterdam: Academic Psychiatric Centre of the Academic Medical Center and the mental health institutions: GGZ Ingeest, Arkin, Dijk en Duin, GGZ Rivierduinen, Erasmus Medical Centre, GGZ Noord Holland Noord. Groningen: University Medical Center Groningen and the mental health institutions: Lentis, GGZ Friesland, GGZ Drenthe, Dimence, Mediant, GGNet Warnsveld, Yulius Dordrecht and Parnassia psycho-medical center The Hague. Maastricht: Maastricht University Medical Centre and the mental health institutions: GGzE, GGZ Breburg, GGZ Oost-Brabant, Vincent van Gogh voor Geestelijke Gezondheid, Mondriaan, Virenze riagg, Zuyderland GGZ, MET ggz, Universitair Centrum Sint-Jozef Kortenberg, CAPRI University of Antwerp, PC Ziekeren Sint-Truiden, PZ Sancta Maria Sint-Truiden, GGZ Overpelt, OPZ Rekem. Utrecht: University Medical Center Utrecht and the mental health institutions Altrecht, GGZ Centraal and Delta).We are grateful to the patients, their families, and healthy subjects for their generosity of time and effort. Furthermore, we would like to thank all research personnel involved in the GROUP project, in particular: Joyce van Baaren, Erwin Veermans, Ger Driessen, Truda Driesen, and Erna van't Hag. Mariam Ali was supported by a master's scholarship from the Graduate School for Medical Science, University of Groningen, Groningen, The Netherlands.
Publisher Copyright:
© 2024 The Authors
PY - 2024/12/1
Y1 - 2024/12/1
N2 - Background: Individuals with schizophrenia commonly experience poor social functioning (SF), influenced by stigmatization and linked to low self-esteem. The intricate role of self-esteem in this context remains insufficiently explored. This study delves into the short and long-term impact of perceived stigma on SF, investigating the mediating or moderating effects of self-esteem and momentary fluctuations in self-esteem. Methods: Data were derived from a longitudinal cohort of individuals with schizophrenia and related disorders from the 2nd (T1) and 3rd (T2) waves. Perceived stigma and self-esteem were measured at T1 with self-report questionnaires. Self-esteem at T2 was measured with the experience sampling method. SF was measured at both time points. Multiple regression was applied to analyse the effect of perceived stigma and the role of (fluctuations in) self-esteem on SF. Results: Perceived stigma significantly correlated with SF in the short-term (ß = -4.66, SE = 1.24, p < 0.001) and long-term (ß = -3.77, SE = 0.51, p < 0.001). Once we analysed samples with self-esteem (N = 157), stigma was still associated with SF (ß = -2.78, SE = 1.36, p = 0.043), but not when self-esteem was controlled for (ß = -2.13, SE = 1.34, p < 0.100). Self-esteem significantly mediated stigma-SF relationship in T1 whereas in T2 it only significantly predicted SF (ß = 2.17, SE = 0.70, p = 0.002). Fluctuations in self-esteem did not show mediating/moderating effects. Conclusion: Perceived stigma significantly predicts poor SF both concurrently and, to some extent, over the long term. Moreover, self-esteem may serve as a buffer that mitigates the negative impact of perceived stigma. Early interventions aimed at reducing stigma and enhancing self-esteem through anti-stigma initiatives are essential for improving SF.
AB - Background: Individuals with schizophrenia commonly experience poor social functioning (SF), influenced by stigmatization and linked to low self-esteem. The intricate role of self-esteem in this context remains insufficiently explored. This study delves into the short and long-term impact of perceived stigma on SF, investigating the mediating or moderating effects of self-esteem and momentary fluctuations in self-esteem. Methods: Data were derived from a longitudinal cohort of individuals with schizophrenia and related disorders from the 2nd (T1) and 3rd (T2) waves. Perceived stigma and self-esteem were measured at T1 with self-report questionnaires. Self-esteem at T2 was measured with the experience sampling method. SF was measured at both time points. Multiple regression was applied to analyse the effect of perceived stigma and the role of (fluctuations in) self-esteem on SF. Results: Perceived stigma significantly correlated with SF in the short-term (ß = -4.66, SE = 1.24, p < 0.001) and long-term (ß = -3.77, SE = 0.51, p < 0.001). Once we analysed samples with self-esteem (N = 157), stigma was still associated with SF (ß = -2.78, SE = 1.36, p = 0.043), but not when self-esteem was controlled for (ß = -2.13, SE = 1.34, p < 0.100). Self-esteem significantly mediated stigma-SF relationship in T1 whereas in T2 it only significantly predicted SF (ß = 2.17, SE = 0.70, p = 0.002). Fluctuations in self-esteem did not show mediating/moderating effects. Conclusion: Perceived stigma significantly predicts poor SF both concurrently and, to some extent, over the long term. Moreover, self-esteem may serve as a buffer that mitigates the negative impact of perceived stigma. Early interventions aimed at reducing stigma and enhancing self-esteem through anti-stigma initiatives are essential for improving SF.
KW - Perceived stigma
KW - Schizophrenia
KW - Self-esteem
KW - Social functioning
KW - Stereotype awareness
U2 - 10.1016/j.schres.2024.10.011
DO - 10.1016/j.schres.2024.10.011
M3 - Article
SN - 0920-9964
VL - 274
SP - 417
EP - 426
JO - Schizophrenia Research
JF - Schizophrenia Research
ER -